Health Care/Hospital

ITRI Took Home Three Edison Awards(TM) in 2023

HSINCHU, April 21, 2023 /PRNewswire/ -- The highly-anticipated 2023 Edison Awards™ winners were revealed in Fort Myers, Florida , and the Industrial Technology Research Institute (ITRI ) is proud to be among them. The ITRI team attended the awa...

2023-04-21 19:27 3147

ImmVira Appoints Dr. Oliver Kong as Chief Medical Officer

SHENZHEN, China, April 20, 2023 /PRNewswire/ -- On April 17, 2023, ImmVira announced the appointment of Dr.Oliver Kong as Chief Medical Officer (CMO). Dr. Kong will be fully in charge of global clinical development and international collaboration of company pipelines, and participate in overall c...

2023-04-21 09:06 2122

More than ten thousand dollars send away as bonuses in the Boston Online Marathon

HOUSTON, April 20, 2023 /PRNewswire/ -- The PitPat Boston Online Marathon is still underway. According to PitPat, more than 1,000 people have signed up and nearly 200 have finished. PitPat Online Marathon The Boston Online Mar...

2023-04-20 23:00 2017

CARsgen's CAR T-cell Candidate CT041 Achieves IND Clearance from the NMPA for the Postoperative Adjuvant Therapy of Pancreatic Cancer

SHANGHAI, April 20, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced that CT041, an autologous CAR T-cell product candidate against the p...

2023-04-20 20:50 2398

Samyang Holdings Enters Partnership with LG Chem for the Development of Innovative Cancer Therapeutics

* Implementation of Samyang Holdings' drug delivery technology for the development of mRNA-based cancer therapeutics SEOUL, South Korea, April 20, 2023 /PRNewswire/ -- Samyang Holdings and LG Chem have announced their recent execution of strategic partnership agreement onThursday, April 20th, f...

2023-04-20 20:30 1776

CBC GROUP AND MUBADALA CO-LEAD US$315 MILLION FUNDRAISING ROUND FOR HASTEN BIOPHARMA

Proceeds raised will be used to fund future acquisitions, and fuel business development of innovative pipeline assets SINGAPORE, April 20, 2023 /PRNewswire/ -- CBC Group ("CBC"), Asia's largest healthcare-dedicated investment firm headquartered inSingapore, and Hasten Biopharmaceutic Company Lim...

2023-04-20 13:00 2220

Innovent Announces Overall Survival Results of Phase 2 Study of Pemazyre® (pemigatinib) in Chinese Patients with Advanced Cholangiocarcinoma Presented at AACR Annual Meeting 2023

ROCKVILLE, Md. and SUZHOU, China, April 19, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology a...

2023-04-20 08:00 1940

500 women join Australia's landmark maternity medical device study

SYDNEY, April 19, 2023 /PRNewswire/ -- Medical device company Baymatob has successfully completed one ofAustralia's largest maternity health studies for a medical device, enrolling 500 mothers in a pilot study to evaluate its AI-guided labor monitoring device, Oli. The device is the only product ...

2023-04-19 21:08 2037

Crystal Pharmatech's CDMO Business Unit - Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability

SUZHOU, China, April 19, 2023 /PRNewswire/ -- Crystal Formulation Services, a subsidiary of Crystal Pharmatech, has achieved an exciting new milestone in its formulation capabilities. The company was recently granted the "Drug Manufacturing License" (C Certificate) by the Jiangsu Medical Products...

2023-04-19 21:00 2112

Concord Medical Files 2022 Annual Report on Form 20-F

BEIJING, April 19, 2023 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extens...

2023-04-19 20:30 3089

Health In Tech to Showcase Cutting-Edge Benefits Solutions at the National Association of Benefits and Insurance Professionals (NABIP)-TX 2023 Conference as a Corporate Sponsor

Be sure to stop by booth #60 to learn more about Health In Tech's suite of offerings for individuals searching for more cost stability and clarity - particularly those facing difficulties due to Humana's departure from the self-funding space. STUART, Fla., April 19, 2023 /PRNewswire/ -- Health I...

2023-04-19 20:30 1828

China Jo-Jo Drugstores Announces the Termination of the Previously Proposed Registered Direct Offering

HANGZHOU, China, April 19, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, announced today that the...

2023-04-19 20:30 2976

Nano Labs Files Annual Report on Form 20-F for Fiscal Year 2022

HANGZHOU, China, April 19, 2023 /PRNewswire/ -- Nano Labs Ltd (Nasdaq: NA) ("we," "the Company," or "Nano Labs"), a leading fabless integrated circuit design company and product solution provider inChina, announced today that it filed its annual report on Form 20-F for the fiscal year endedDecemb...

2023-04-19 19:00 2854

Cali Biosciences Initiates Phase III Studies of CPL-01 (Long-Acting Ropivacaine) to Decrease Post-Operative Pain and Reduce or Eliminate Opioid Use

- Subjects in Herniorrhaphy Study Dosed - Successful FDA Interactions on Two Pre-clinical Pipeline Products Also Discussed SAN DIEGO, April 18, 2023 /PRNewswire/ -- Cali Biosciences Co., Ltd. (hereinafter referred to as "Cali" or "Cali Biosciences"), a biopharmaceutical company focused on the re...

2023-04-19 11:05 1608

Nona Biosciences and Washington University Join Forces to Tackle Emerging RNA Viruses

CAMBRIDGE, Mass., April 18, 2023 /PRNewswire/ -- Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited, committed to cutting edge technology innovation and provider of integrated solutions from "Idea to IND" (I to ITM), announced today it has entered into a collaboration agreement w...

2023-04-19 08:45 2006

AACR 2023 | ImmVira presented preclinical study results of first CAR-T enabler oncolytic product MVR-T7011 at AACR Annual Meeting

SHENZHEN, China, April 17, 2023 /PRNewswire/ -- On April 18, 2023, U.S. time, ImmVira presented preclinical study results of CAR-T enabler oHSV product MVR-7011 through poster publication at the American Association for Cancer Research ("AACR") annual meeting.

2023-04-19 08:29 1733

Bridge Biotherapeutics Releases Updated Preclinical Data for BBT-207 at the AACR Annual Meeting

* New preclinical data validate anti-tumor efficacy and intracranial activity of the drug candidate * Bridge submitted an IND application to the U.S. Food and Drug Administration in March, and expects to initiate the first-in-human study of BBT-207 this year SEONGNAM, South Korea and CAMBRIDG...

2023-04-19 07:00 1792

The Korea Health Industry Development Institute runs the Korean Pavilion at the 2023 HIMSS Global Health Conference and Exhibition

- Promoting the products of Korean digital healthcare companies and supporting the progress into the global market at the world's largest medical IT exhibition - CHICAGO and SEOUL, South Korea, April 18, 2023 /PRNewswire/ -- Korea Health Industry Development Institute (President Cha Soon-do, her...

2023-04-19 00:05 1707

State-owned Fund Joins Huayi Tencent's "Echartnow" Series A Financing, Kickstarting Its IPO Plan

HONG KONG, April 18, 2023 /PRNewswire/ -- Huayi Tencent Entertainment Company Limited("Huayi Tencent Entertainment", the "Company"; Stock code: 419.HK; together with its subsidiaries collectively known as the "Group") and its subsidiary "Shaanxi Yizhinuo Information Technology Company Limited" (t...

2023-04-18 23:26 2792

China Jo-Jo Drugstores Announces $7 Million Registered Direct Offering

HANGZHOU, China, April 18, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that it ...

2023-04-18 21:21 2343
1 ... 102103104105106107108 ... 277

Week's Top Stories